Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians
Pathogens · 2024
DOI: 10.3390/pathogens13070573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Moeen Hamid Bukhari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Quaid-i-Azam University, Islamabad 45320, Pakistan. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Coinfection, Severe Dengue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Few studies have investigated whether SARS-CoV-2 infections increase the incidence of dengue haemorrhagic fever/shock syndrome (DHF/DSS) and/or severe dengue (SD) in dengue virus (DENV)-infected patients. This study was performed on a site with high incidences of classical dengue, but relatively few DHF/DSS or SD cases as defined by the WHO 1997 or 2009 criteria, respectively. Clinical, haematological/biochemical, and viral diagnostic data were collected from febrile patients before, during, and after the COVID-19 epidemic to assess whether (a) DENV-infected patients with prior SARS-CoV-2 infections or (b) DENV-SARS-CoV-2-co-infected patients had increased incidences of SD/DHF/DSS using logistic regression and machine learning models. Higher numbers of DHF/DSS/SD occurred during the COVID-19 epidemic, particularly in males and 18–40-year-olds. Significantly increased symptoms in the DENV-SARS-CoV-2-co-infected cases were (a) haemoconcentration (p < 0.0009) and hypotension (p < 0.0005) (DHF/DSS and SD criteria), (b) thrombocytopenia and mucosal bleeding (DHF/DSS-criteria), (c) abdominal pain, persistent vomiting, mucosal bleeding, and thrombocytopenia (SD warning signs) and (d) dyspnoea, but without fluid accumulation. DENV-infected patients with prior SARS-CoV-2 infections had significantly increased incidences of thrombocytopenia (DHF/DSS-criteria) and/or abdominal pain and persistent vomiting and also thrombocytopenia (SD warning signs), but without significant haemoconcentration or hypotension. DENV-SARS-CoV-2 co-infections significantly increased the incidence of DHF/DSS/SD, while DENV-infected patients with prior SARS-CoV-2 infections displayed significantly increased incidences of thrombocytopenia (DHF/DSS-criteria) and three important SD warning signs, which are therefore very important for health workers/clinicians in assessing patients’ DHF/DSS/SD risk factors and planning their optimal therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics, Quaid-i-Azam University, Islamabad 45320, Pakistan.
- Centre for Health and Wellbeing, School of Public and International Affairs, Princeton University, Princeton, NJ 08544, USA.
- Rutgers Global Health Institute, New Brunswick, NJ 08901, USA.
- Department of Biostatistics and Epidemiology, School of Public Health, Rutgers University, Piscataway, NJ 08901, USA.
- District Department of Health of Barranquilla, Barranquilla 080003, Colombia.
- Laboratory of Tropical Diseases, Department of Medicine, Health Division, Universidad del Norte, Barranquilla 080003, Colombia.
ORCID-Profile: Andrew K I Falconar, Claudia M Romero-Vivas
Zitieren
APA
Bukhari, M. H., Annan, E., Haque, U., Arango, P., Falconar, A. K. I., & Romero-Vivas, C. M. (2024). Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians. Pathogens. https://doi.org/10.3390/pathogens13070573
Vancouver
Bukhari MH, Annan E, Haque U, Arango P, Falconar AKI, Romero-Vivas CM. Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians. Pathogens. 2024. doi:10.3390/pathogens13070573
BibTeX
@article{Bukhari2024,
author = {Bukhari, Moeen Hamid and Annan, Esther and Haque, Ubydul and Arango, Pedro and Falconar, Andrew K I and Romero-Vivas, Claudia M},
title = {Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13070573}
}
EUVIMED